biomanufacturing
biomanufacturing
Robots and AI Revolutionize Cell and Gene Therapy Manufacturing!
🤖🔬 Researchers suggest that robots and AI can address manufacturing challenges in cell and gene therapy. ⬆️🌍 The industry is growing rapidly, requiring skilled personnel and increased production. 🤖🔬 Automation and AI can improve efficiency and reduce costs.
MilliporeSigma’s €300 Million Investment Fuels South Korea’s Bioproduction Boom
📢 MilliporeSigma invests €300 million in South Korea bioproduction site, creating 300 jobs and supporting biotech and pharma industries. 🏭💼🧪🧬
Revolutionizing Bioprocessing with Integrated Microfluidics
📝 Bioprocessing can benefit from the integration of microfluidic devices, similar to how integrated circuits transformed computing. 🌡️ Microfluidics offer advantages such as testing multiple variables quickly and using low reagent levels. 🧪 Researchers developed an integrated microfluidic device for continuous bioprocessing, allowing for the screening and optimization of multiple conditions. 🔬 The device demonstrated consistent production of green fluorescent protein (GFP) over eight days. ⏱️ Integrated microfluidic devices have the potential to revolutionize biomanufacturing with rapid screening and optimization capabilities.
Game-Changing Cancer Immunotherapy Deal Unveiled
📰 Domain Therapeutics and Chime Biologics join forces to develop an anti-CCR8 antibody for cancer immunotherapy! 👥💉 Exciting times ahead! 🤝
IIT Madras Teams Up with Vellon Space to Revolutionize Biomanufacturing in Space
🚀 IIT Madras partners with Vellon Space to advance biomanufacturing in microgravity, revolutionizing cell culture in space.
Agathos Launches Game-Changing rAAV Service: Ethical Cell Line Revolutionizes Biomanufacturing
🔍 Agathos Biologics launches rAAV production service using AE1-BHK cell line, records first sale to Genovac. 💡✅🔬🌐
WHO Launches Biomanufacturing Training to Boost Global Vaccine Production
🌍 WHO launches Biomanufacturing Workforce Training Initiative to improve bioproduction in LMICs. 🏭💪🔬 Enhancing local vaccine production and building capacity.
Boost AAV Genome Production with RevIT Enhancer!
🚀 Boost AAV genome production with RevIT™ AAV Enhancer! 🧬💰 Increase titers, streamline workflows, and save costs in gene therapy manufacturing.
Revolutionizing Biomanufacturing: Faster Cheaper and More Efficient
🧪 Quick production of therapeutics and vaccines using a disease-agnostic platform approach. 📊 Improved mRNA yields in just two hours. 🖥️ Real-time process monitoring and control. 💉 Billions of vaccine doses produced using a platform process. 🧫 Efficient and cost-effective allogeneic cell therapies. 🌐 Scalable, monitored, and controlled manufacturing of advanced therapies and vaccines. 💡 Future perspective: reducing costs and manufacturing risk with platform-based iPSC production.
Revolutionary Partnership Expands Cell Therapy Development
📰 Multiply Labs and Thermo Fisher join forces to revolutionize cell therapy production! 💼🔬 Accelerating development and commercialization for patients. 🏭
